MORPHOSYS AG
Patent Owner
Stats
- 48 US PATENTS IN FORCE
- 12 US APPLICATIONS PENDING
- Mar 01, 2018 most recent publication
Details
- 48 Issued Patents
- 0 Issued in last 3 years
- 0 Published in last 3 years
- 1,725 Total Citation Count
- Feb 17, 1994 Earliest Filing
- 36 Expired/Abandoned/Withdrawn Patents
Patent Activity in the Last 10 Years
Technologies
Intl Class
Technology
Matters
Rank in Class
Top Patents (by citation)
Upgrade to the Professional Level to View Top Patents for this Owner. Learn More |
Recent Publications
Publication #
Title
Filing Date
Pub Date
Intl Class
2014/0255,427 COMBINATION THERAPY WITH AN ANTI - CD19 ANTIBODY AND A NITROGEN MUSTARDAug 14, 12Sep 11, 14[A61K]
Recent Patents
Patent #
Title
Filing Date
Issue Date
Intl Class
9765152 Method for the treatment of multiple myeloma or non-Hodgkins lymphoma with anti-CD38 antibody and bortezomib or carfilzomibFeb 05, 16Sep 19, 17[A61K, C07K]
Expired/Abandoned/Withdrawn Patents
Patent #
Title
Status
Filing Date
Issue/Pub Date
Intl Class
2015/0197,579 Complex-specific antibodies and antibody fragments and its useAbandonedAug 08, 13Jul 16, 15[G01N, C07K]
2014/0234,298 THERAPEUTIC COMBINATIONS OF ANTI-CD20 AND ANTI-GM-CSF ANTIBODIES AND USES THEREOFAbandonedJul 06, 12Aug 21, 14[C07K]
2014/0011,698 SIMULTANEOUS DETECTION OF BIOMOLECULES IN SINGLE CELLSAbandonedNov 30, 11Jan 09, 14[G01N]
8551733 Production of oligoclonal mixtures of immunoglobulins in single cellsExpiredFeb 08, 10Oct 08, 13[C12P]
2012/0189,622 ANTI-CD38 HUMAN ANTIBODIES AND USES THEREOFAbandonedMar 22, 12Jul 26, 12[A61K, C12N, A61P, C07K]
2012/0165,230 BIOLOGICALLY PRODUCED CYCLIC AFFINITY TAGSAbandonedJun 23, 10Jun 28, 12[C12P, C40B, C07K]
2012/0116,059 Treatment For MTreatment For Multiple SclerosisAbandonedMay 04, 10May 10, 12[A61P, C07K]
2011/0110,944 ANTI-ALK1 ANTIBODIES AND USES THEREOFAbandonedApr 24, 09May 12, 11[A61K, C07H, C12N, A61P, C40B, C07K]
2010/0317,546 Display Vectors and Methods and Uses ThereofAbandonedJan 09, 09Dec 16, 10[C12Q, C12P, C12N, C40B]
2010/0291,078 Proteinaceous binding molecules comprising purification tags or inert variable domainsAbandonedJan 21, 09Nov 18, 10[A61K, C07H, C12N, G01N, C07K]
7785591 Identification and characterization of function-blocking anti-ED-B-fibronectin antibodiesExpiredOct 14, 05Aug 31, 10[A61K, G01N, C07K]
2010/0119,506 Effectors of PAR-2 Activation and Their Use in the Modulation of InflammationAbandonedJul 30, 09May 13, 10[A61K, A61P, C07K]
2009/0123,950 Generation And Profiling Of Fully Human Hucal Gold®-Derived Therapeutic Antibodies Specific For Human CD38AbandonedMay 24, 06May 14, 09[C12Q, G01N]
Top Inventors for This Owner
Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More |
We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!
We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.